BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Salameh H, Masadeh M, Al Hanayneh M, Petros V, Maslonka M, Nanda A, Singal AK. PNPLA3 polymorphism increases risk for and severity of chronic hepatitis C liver disease. World J Hepatol 2016; 8(35): 1584-1592 [PMID: 28050240 DOI: 10.4254/wjh.v8.i35.1584]
URL: https://www.wjgnet.com/1007-9327/full/v8/i35/1584.htm
Number Citing Articles
1
Rocío Aller, Cristina Laserna, Miguel Ángel Rojo, Natalia Mora, Concepción García Sánchez, María Pina, Rebeca Sigüenza, Miguel Dur�, David Primo, Olatz Izaola, Daniel de Luis. Role of the PNPLA3 polymorphism rs738409 on silymarin + vitamin E response in subjects with non-alcoholic fatty liver diseaseRevista Española de Enfermedades Digestivas 2018; 110 doi: 10.17235/reed.2018.5602/2018
2
Tanvi Agrawal, Anuj Gaggar, Mani Subramanian, Shyam Kottilil, Abhijit Choudhary, Padaki N. Rao, Sameer Shah, Nirupma Trehanpati. PNPLA3 polymorphisms are associated with raised alanine aminotransferase levels in hepatitis C virus genotype 3Arab Journal of Gastroenterology 2020; 21(4): 267 doi: 10.1016/j.ajg.2020.09.002
3
Joseph L. Dempsey, George N. Ioannou, Rotonya M. Carr. Mechanisms of Lipid Droplet Accumulation in Steatotic Liver DiseasesSeminars in Liver Disease 2023; 43(04): 367 doi: 10.1055/a-2186-3557
4
Arthur Ivan N. Oliveira, Fernanda M. Malta, Patricia Momoyo Y. Zitelli, Ana Paula M. Salles, Michele S. Gomes-Gouvea, Ana Catharina S. Nastri, Joao Renato R. Pinho, Flair J. Carrilho, Claudia P. Oliveira, Maria Cássia Mendes-Corrêa, Mario G. Pessoa, Daniel F. Mazo. The role of PNPLA3 and TM6SF2 polymorphisms on liver fibrosis and metabolic abnormalities in Brazilian patients with chronic hepatitis CBMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-021-01654-3